- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05160181
Impact of Yogotherapeutics on Chronic Pains' Patients (YOGADO)
Impact of Yogotherapeutics in Consultation on Chronic Pains' Patients
Aperçu de l'étude
Description détaillée
Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation.
Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology.
More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain.
To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France.
Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Pontoise, France, 95300
- Departement of Chronic Pain Consultation, Hospital René Dubos,
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Patient ≥ 18 years old,
- Seen in consultation for chronic pain with implementation of Yogatherapy,
Exclusion Criteria:
- Patient < 18 years old,
- No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder),
- Trauma pathology and / or acute fracture in progress,
- Patient refusal to participate.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Yogatherapy
Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Evolution of the patient's pain
Délai: Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Evolution of the patient's pain over time
Délai: Between the 1st and the 5th consultation, an average of 3 to 5 month
|
The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)
|
Between the 1st and the 5th consultation, an average of 3 to 5 month
|
Improvement of patient's sleep
Délai: Between the 1st and the last consultation, an average of 5 to 10 month
|
The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
Evolution of the patient's quality of life
Délai: Between the 1st and the last consultation, an average of 5 to 10 month
|
The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10 Results are interpreted as following : EN ≤ 5 = Very degraded, 6 ≥ EN ≤ 7 = Degraded and EN > 7 = Normal) |
Between the 1st and the last consultation, an average of 5 to 10 month
|
Evolution of the patient's therapeutic
Délai: Between the 1st and the last consultation, an average of 5 to 10 month
|
The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies.
|
Between the 1st and the last consultation, an average of 5 to 10 month
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Jocelyne BOREL-KUHNER, Hospital René Dubos,
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CHRD1119
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur La douleur chronique
-
Evergrain, LLCINQUIS Clinical Research Ltd.ComplétéSatiété du pain riche en fibres et riche en protéinesCanada
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceComplétéChangements de poids corporel | Modification alimentaire | Microbiote gastro-intestinal | Pain | Tests hématologiquesIsraël
-
University of BergenUniversity of Leipzig; Chalmers University of Technology; Nofima; Paderborn UniversityComplétéHyperglycémie | Prédiabète | Contrôle glycémique | PainNorvège
-
Ege UniversityComplétéObésité | Index glycémique | Glucose sanguin | PainTurquie
-
PfizerComplétéLeucémie, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositifFrance, États-Unis, Canada, Espagne, Tchéquie, Singapour, Thaïlande, Danemark, Norvège, Corée, République de, Finlande, Hongrie, Suède, Pays-Bas, Italie, Allemagne, Ukraine, Afrique du Sud, Taïwan, Australie, Belgique, Israël, Mexique, Pologn... et plus